Skip to main content
. 2023 Dec 1;19(12):1997–2004. doi: 10.5664/jcsm.10752

Table 3.

Upper airway stimulation therapy efficacy for obstructive sleep apnea metrics.

Characteristic n Overall (n = 274) OSAa (n = 126) COMISA (n = 148) P a
ESS preop 180 9.9 (5.2) 10.5 (5.6) 9.4 (4.9) .2
Postop change in ESS 78 −3.0 (4.8) −3.3 (5.1) −2.8 (4.6) .5
AHI preop 274 33.5 (13.7) 34.0 (14.0) 33.1 (13.5) .6
AHI change 260 −17.8 (18.1) −18.0 (17.4) −17.6 (18.7) >.9
ODI preop 100 27.3 (13.6) 28.8 (13.3) 25.9 (13.9) .3
Postop change in ODI 73 −12.5 (18.0) −10.8 (19.1) −14.4 (16.8) .8
T88% 213 27.5 (61.9) 39.3 (84.6) 17.0 (26.2) .02
T88% change 163 −7.6 (74.8) −18.8 (93.1) 4.5 (45.0) .11

Data are presented as mean (standard deviation) unless otherwise indicated. aWilcoxon rank-sum test. All changes in ESS, AHI, ODI and T88% are significant (P < .01) across the entire cohort and OSAa and COMISA subcohorts. AHI = apnea-hypopnea index, COMISA = comorbid insomnia and obstructive sleep apnea, ESS = Epworth Sleepiness Scale, ODI = oxygen desaturation index, OSAa = obstructive sleep apnea alone, postop = postoperatively, preop = preoperatively, SaO2 = oxygen saturation, T88% = minutes below oxygen saturation of 88%.